Lv和血管生成:一个新发现的血管生成
Dylan L Pham1,2, Kelsey Cox1, Michael L Ko1,3
1Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX 77843, USA.
Biomedicines
|January 8, 2025
概括
Lv是一种小蛋白质,影响血管的生长和功能. 它显示出开发新疗法的潜力,用于涉及异常血管形成的疾病.
科学领域:
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
- 内分泌学 在内分泌学.
背景情况:
- Lv是一种保存的分泌,具有多种生物活性.
- 最初因其在增加神经元中的L型电压通道 (LTCC) 中的作用而被确定.
- Lv还与血管内皮生长因子受体2 (VEGFR2) 相互作用,表现出类似VEGF的特性.
研究的目的:
- 审查Lv.的已知生物活性.
- 探索其在血管生成中的作用和临床相关性.
- 为未来与Lv.相关的治疗开发提供基础.
主要方法:
- 对Lv.的现有研究的文献综述.
- 在体外和体外实验数据的分析.
- 对临床相关性的检查,特别是在糖尿病视网膜病变中.
主要成果:
- Lv可以增加神经元和心肌细胞中的LTCCs.
- 它促进了血管内皮细胞中的KCa3.1通道表达.
- Lv表现出类似于VEGF的活动,包括血管扩张和血管生成促进.
结论:
- Lv在血管生成中起着重要作用.
- 它在糖尿病视网膜病变中的上调表明它参与了病理性血管生成.
- 酸Lv在血管生成相关疾病中具有治疗应用的潜力.
相关概念视频
01:24Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
01:10Mechanism of Angiogenesis
5.2K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.2K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K